Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages

Cell Death Dis. 2020 Jan 23;11(1):53. doi: 10.1038/s41419-020-2237-2.

Abstract

Thrombospondin-4 (TSP-4) attracted renewed attention recently as a result of assignment of new functions to this matricellular protein in cardiovascular, muscular, and nervous systems. We have previously reported that TSP-4 promotes local vascular inflammation in a mouse atherosclerosis model. A common variant of TSP-4, P387-TSP-4, was associated with increased cardiovascular disease risk in human population studies. In a mouse atherosclerosis model, TSP-4 had profound effect on accumulation of macrophages in lesions, which prompted us to examine its effects on macrophages in more detail. We examined the effects of A387-TSP-4 and P387-TSP-4 on mouse macrophages in cell culture and in vivo in the model of LPS-induced peritonitis. In tissues and in cell culture, TSP-4 expression was associated with inflammation: TSP-4 expression was upregulated in peritoneal tissues in LPS-induced peritonitis, and pro-inflammatory signals, INFγ, GM-CSF, and LPS, induced TSP-4 expression in macrophages in vivo and in cell culture. Deficiency in TSP-4 in macrophages from Thbs4-/- mice reduced the expression of pro-inflammatory macrophage markers, suggesting that TSP-4 facilitates macrophage differentiation into a pro-inflammatory phenotype. Expression of TSP-4, especially more active P387-TSP-4, was associated with higher cellular apoptosis. Cultured macrophages displayed increased adhesion to TSP-4 and reduced migration in presence of TSP-4, and these responses were further increased with P387 variant. We concluded that TSP-4 expression in macrophages increases their accumulation in tissues during the acute inflammatory process and supports macrophage differentiation into a pro-inflammatory phenotype. In a model of acute inflammation, TSP-4 supports pro-inflammatory macrophage apoptosis, a response that is closely related to their pro-inflammatory activity and release of pro-inflammatory signals. P387-TSP-4 was found to be the more active form of TSP-4 in all examined functions.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Biomarkers / metabolism
  • Cell Survival / drug effects
  • Cytokines / metabolism
  • Inflammation / pathology*
  • Inflammation Mediators / metabolism
  • Lipopolysaccharides / pharmacology
  • Macrophages, Peritoneal / drug effects
  • Macrophages, Peritoneal / metabolism
  • Macrophages, Peritoneal / pathology*
  • Mice
  • Mice, Inbred C57BL
  • Monocytes / drug effects
  • Monocytes / pathology
  • Peritonitis / pathology
  • Phenotype
  • Phosphorylation / drug effects
  • RAW 264.7 Cells
  • Recombinant Proteins / pharmacology
  • Thrombospondins / metabolism*

Substances

  • Biomarkers
  • Cytokines
  • Inflammation Mediators
  • Lipopolysaccharides
  • Recombinant Proteins
  • Thrombospondins
  • thrombospondin 4